NASDAQ NMS - GLOBAL MARKET · INBX
+1.08% · +$1.12 · Vol 373.6K
Market closed · last close 4:00 PM ET · price as of 18:28:30 ET
Inhibrx Biosciences Inc

Inhibrx Biosciences Inc

Biotechnology
$104.75
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Valuation absence reason unknown · Sentiment absence reason unknown
INBX
Inhibrx Biosciences Inc
Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

62/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INBX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INBX catalysts
About Inhibrx Biosciences Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2024
Employees
110
Country
US

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$105.00
Day high
$105.14
Day low
$94.20
Previous close
$103.63
52W high
$141.84
-26.15% from high
52W low
$25.04
68% of range
Market cap
$1.5B
EPS
$-9.5700
Beta
2.11
Shares out
14.7M
Volume
373.6K
1.55× rel vol
Avg volume
240.3K
VWAP
$100.24
Price history computed in-house
1W
+10.71%
1M
+28.45%
3M
+1.70%
1Y
+318.33%
YTD
+32.59%
SMA 50 $91.74 · above
SMA 200 $86.91 · above
52W position 68%

INBX overview

Veridion Score
62
Registered · 2026-08-24
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INBX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INBX Form 4 filings
Public disclosures

Congress activity in INBX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for INBX in the cached public ledger.

Federal contracts

INBX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INBX in this window.
Lobbying spend

INBX lobbying filings, year to date.

Registered lobbying filings matched to Inhibrx Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INBX in this window.
Loading news for INBX
Analyst ratings
Sovereign unlock shows live analyst consensus for INBX.
Options
Sovereign unlock shows live options positioning for INBX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.